MedETechni develops AI-driven UV phototherapy devices, specifically the Virgilio Rays, to accelerate the healing of chronic wounds and enhance sterilization processes in clinical settings. This technology significantly reduces healing time for conditions like venous ulcers, improving patient outcomes and operational efficiency in healthcare facilities.
Funding
$300K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Chronic wounds, such as venous ulcers, require extended healing times, leading to patient discomfort and increased healthcare costs. Traditional sterilization methods in clinical settings may not be as efficient or effective as desired, potentially increasing the risk of infection.
Solution
MedETechni develops AI-driven UV phototherapy devices, including the Virgilio Rays, designed to accelerate the healing of chronic wounds and improve sterilization processes. The Virgilio Rays device aims to reduce healing times for conditions like venous ulcers, thereby enhancing patient outcomes and improving operational efficiency in healthcare facilities. The company also offers Tesla UV Rays for advanced sterilization in hospitals and clinics.
Target Audience
The primary customers are healthcare facilities, including hospitals and clinics, specializing in chronic wound treatment and seeking advanced sterilization solutions.
Features
- AI-driven UV phototherapy for targeted treatment.
- Virgilio Rays device for accelerating the healing of chronic wounds.
- Tesla UV Rays for advanced sterilization in clinical settings.